Decellularized aortic homografts versus mechanical composite grafts for aortic root replacement
European Journal of Cardio-Thoracic Surgery · 2024
DOI: 10.1093/ejcts/ezae314 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2024. Verfasst von Alexandra Andreeva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Aortic Valve, Heart Valve Prosthesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVES Mechanical composite valve grafts (MCVGs) are the first-line therapy for aortic root replacement in young adults. Decellularized aortic homografts (DAH) present a promising novel alternative due to their lower thrombogenicity. We aimed to compare both treatment options regarding survival and valve-related adverse events. METHODS This study was designed as a single-centre retrospective cohort study including patients who underwent root replacement with MCVG or DAH between 2000 and 2022. Urgent or emergent procedures were excluded. RESULTS The study cohort included 289 patients (MCVG n = 216, DAH n = 73) with a mean age of 48.5 ± 12 years (MCVG 49 ± 12 years vs DAH 47 ± 11 years; P = 0.23) and a median EuroScore II of 1.7% (1.2, 2.6). The 30-day mortality was 1% (n = 3). Cumulative survival at 3 years was 99% for DAH and 94% for MCVG, respectively (P = 0.15). Mean follow-up was 98.9 ± 72.7 months. Bleeding events (n = 14, 6.5%) and thromboembolism (n = 14, 6.5%) were only observed in the MCVG group (P = 0.19 and 0.09, respectively). Four cases (5%) of moderate structural valve deterioration occurred, all in the DAH group (P ≤ 0.001). The cumulative incidence of a composite end point of valve-related adverse events was significantly higher in the MCVG group (P = 0.0295). CONCLUSIONS Aortic root replacement with MCVGs and decellularized aortic homografts showed low mortality in an elective setting. Patients in the homograft cohort demonstrated significantly higher freedom from valve-related adverse events. DAH present a promising treatment option for young patients requiring root replacement; however, data on long-term durability are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Alexandra Andreeva, Paul Werner, Iuliana Coti, Alfred Kocher, Guenther Laufer, Daniel Zimpfer, Martin Andreas
Zitieren
APA
Andreeva, A., Werner, P., Coti, I., Kocher, A., Laufer, G., Ehrlich, M., Zimpfer, D., & Andreas, M. (2024). Decellularized aortic homografts versus mechanical composite grafts for aortic root replacement. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezae314
Vancouver
Andreeva A, Werner P, Coti I, Kocher A, Laufer G, Ehrlich M, et al. Decellularized aortic homografts versus mechanical composite grafts for aortic root replacement. European Journal of Cardio-Thoracic Surgery. 2024. doi:10.1093/ejcts/ezae314
BibTeX
@article{Andreeva2024,
author = {Andreeva, Alexandra and Werner, Paul and Coti, Iuliana and Kocher, Alfred and Laufer, Guenther and Ehrlich, Marek and Zimpfer, Daniel and Andreas, Martin},
title = {Decellularized aortic homografts versus mechanical composite grafts for aortic root replacement},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
doi = {10.1093/ejcts/ezae314}
}
EUVIMED